about
Left Atrial Myxoma Hypervascularized from the Right Coronary Artery: An Interesting Cath Lab Finding.Early ambulation and variability in anticoagulation during elective coronary stenting with a single intravenous bolus of low-dose, low-molecular weight heparin enoxaparinCoronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II)Three-dimensional reconstruction of coronary arteries and plaque morphology using CT angiography--comparison and registration with IVUSOn the search of arterial geometry heritability.Quantification of scientific output in cardiovascular medicine: a perspective based on global data.TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortalityOne-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trUsefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).Ex-vivo Assessment of Coronary Artery Atherosclerosis by Magnetic Resonance Imaging: Correlation with Histopathology.Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM TrialMTRR rs326119 polymorphism is associated with plasma concentrations of homocysteine and cobalamin, but not with congenital heart disease or coronary atherosclerosis in Brazilian patients.LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiographyPhosphorus is associated with coronary artery disease in patients with preserved renal functionInvestigation route of the coronary patient in the public health system in Curitiba, São Paulo and in InCor--IMPACT studyDevelopment of a closed-artery catheter-based myocardial infarction in pigs using sponge and lidocaine hydrochloride infusion to prevent irreversible ventricular fibrillation.Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy.A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary arteriesSirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II).Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.Long term outcome after intracoronary beta radiation therapy.Coronary CT angiography using 64 detector rows: methods and design of the multi-centre trial CORE-64.Recurrent angina after revascularization: an emerging problem for the clinician.Differences determined by optical coherence tomography volumetric analysis in non-culprit lesion morphology and inflammation in ST-segment elevation myocardial infarction and stable angina pectoris patients.Drug-eluting stents: from randomized trials to the real world.Left Main Compression by a Giant Aneurysm of the Left Sinus of Valsalva: An Extremely Rare Reason for Myocardial Infarction and Cardiogenic Shock.Performance of surgical risk scores to predict mortality after transcatheter aortic valve implantation.MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian populationIntravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trialDoes Ad Hoc Coronary Intervention Reduce Radiation Exposure? - Analysis of 568 PatientsClinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry.Total coronary atherosclerotic plaque burden assessment by CT angiography for detecting obstructive coronary artery disease associated with myocardial perfusion abnormalities.Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement.The role of invasive therapies in elderly patients with acute myocardial infarction.Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention.Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting.Left main stenting: do we need another study?Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature.
P50
Q27313290-2E69DB02-AA41-4D3E-BBF5-3823245A2FACQ28194725-8A989FC0-17CF-4819-A8CC-0A3C05BE34A7Q28199060-4F5BF835-661A-47FE-9621-A6D9D2D271D4Q30393301-3E4EB0AB-519C-4E91-BBEB-AC466B376C7DQ30489596-3AACBD39-F48A-474C-8958-8B5513595E21Q30669791-3693AEF0-52E8-45CF-AA11-CE8CF5BDC4B8Q30895121-E2C93696-9246-48C7-8FA2-4EA477E09509Q30997981-6161A2A6-4345-4E15-BE5B-8943E258D76BQ33363035-42F5709E-2245-4F8E-990F-75BA9630A4D7Q33378384-EE61DB3E-F0BD-4F75-8A25-8E9360E06180Q33612030-B6F110B6-5947-4561-9337-D1461D4B2F24Q33709966-E6EF6F78-D99F-4AC4-B90F-BB9CFB81FA60Q33753471-2513F623-DAE0-4387-857D-2B5599180C4EQ33939240-E91CFCC4-D7BE-4526-B963-B54C8194CEA5Q34271082-04732850-A962-4CAB-8BF0-2ECB839D84E5Q34319896-E6FF5BE6-B03C-4F2B-AF95-26BFB6FC1EE6Q34582306-B544EF9A-9974-4A7A-ADED-CC4402248701Q35177599-8CC9A88B-03C3-4ABF-AE18-A6622DF49EC6Q35572141-E502F43E-3ED9-4A05-9F73-114B597EBD87Q35582847-45A27DC0-1855-4677-A977-4B46A63F8D24Q35583034-31DA75A0-896A-4EB0-BA53-B2BBC90BBC09Q35584438-E18ECED0-9DF6-4168-833D-0A2BBD90F1DFQ35789136-C48C7FA7-0549-4F72-913B-40402BAC3910Q35792946-5F69279B-6ADA-4CFF-9F95-311AEF3CB9D9Q35794203-F59CBF30-3E47-4C80-A64D-0F508472A648Q35932987-DDA80C4D-2FF8-46A3-B22E-6FA6B64022A5Q36103211-D9A1B281-1712-421D-B14A-1B38E88952A7Q36117008-4FBBFA10-9FA3-4CF5-B3D1-62AEC5EBA8DCQ36226649-B36CC95F-82E9-4889-9285-3EF8CBB4E50CQ36262721-FBC95F71-F5C5-446D-9032-D020B4814411Q36295794-63B9125C-AFBA-45F4-8F74-4DA309AE8376Q36602870-4664EF1D-F8E3-492B-90EE-EF2902B373F5Q36678034-5BA0E736-B2C4-4F06-BC3D-D8A90647DBE2Q36785716-349D7B40-C0FC-42D9-A64E-416AB26DA005Q37248944-E2EAF540-784A-44CB-A04C-805ED876268EQ37285036-83E066D4-9884-49D2-8C69-7BA008A2FF39Q37520147-858F0CE2-F6DB-4AFA-977F-615C158FC649Q37856434-18A6A549-3BBC-419A-9DC4-B82D18158433Q37935337-950BB5EC-0840-44CA-8498-3BB4B7600D05Q38090308-BF24FC25-EBBB-46BB-BC3B-C5073611E31E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Pedro A Lemos
@ast
Pedro A Lemos
@en
Pedro A Lemos
@es
Pedro A Lemos
@sl
type
label
Pedro A Lemos
@ast
Pedro A Lemos
@en
Pedro A Lemos
@es
Pedro A Lemos
@sl
prefLabel
Pedro A Lemos
@ast
Pedro A Lemos
@en
Pedro A Lemos
@es
Pedro A Lemos
@sl
P214
P244
P1053
G-5758-2013
P106
P21
P214
P244
nb2004305339
P31
P3829
P496
0000-0002-6782-750X
P735
P7859
lccn-nb2004305339